Zena Wehbe
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 4
-
- Extracellular vesicles in disease 3
- Co-authors
- Ali H. Eid (11 shared papers)Ahmed F. El‐Yazbi (4 shared papers)Gianfranco Pintus (5 shared papers)Hassan Zaraket (4 shared papers)Roberta Giordo (3 shared papers)Arduino A. Mangoni (2 shared papers)Suzanne A. Nasser (1 shared paper)Hadi M. Yassine (2 shared papers)
In The Last Decade
Zena Wehbe
13 papers receiving 331 citations
Peers
Comparison fields: 5 of 82
- Infectious Diseases 121
- Neurology 85
- Biochemistry 15
- Cancer Research 35
- Health, Toxicology and Mutagenesis 31
Countries citing papers authored by Zena Wehbe
This map shows the geographic impact of Zena Wehbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zena Wehbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zena Wehbe more than expected).
Fields of papers citing papers by Zena Wehbe
This network shows the impact of papers produced by Zena Wehbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zena Wehbe. The network helps show where Zena Wehbe may publish in the future.
Co-authors
The 25 scholars most cited alongside Zena Wehbe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 47 | |
| 2 | 2020 | 44 | |
| 3 | 2022 | 40 | |
| 4 | 2021 | 34 | |
| 5 | 2020 | 30 | |
| 6 | 2022 | 29 | |
| 7 | 2021 | 29 | |
| 8 | 2023 | 24 | |
| 9 | 2021 | 24 | |
| 10 | 2020 | 14 | |
| 11 | 2024 | 7 | |
| 12 | 2021 | 7 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 0 |
About Zena Wehbe
Zena Wehbe is a scholar working on Infectious Diseases, Molecular Biology, Cancer Research, Neurology and Cardiology and Cardiovascular Medicine, having authored 14 papers that have together received 333 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Long-Term Effects of COVID-19 (3 papers), MicroRNA in disease regulation (3 papers), Extracellular vesicles in disease (3 papers), Nanoplatforms for cancer theranostics (1 paper), Natural Antidiabetic Agents Studies (1 paper) and Psidium guajava Extracts and Applications (1 paper). The work is most often cited by research in Infectious Diseases (121 citations), Neurology (85 citations), Biochemistry (15 citations), Cancer Research (35 citations) and Health, Toxicology and Mutagenesis (31 citations). Zena Wehbe has collaborated with scholars based in Lebanon, Qatar and Italy. Frequent co-authors include Ali H. Eid, Ahmed F. El‐Yazbi, Gianfranco Pintus, Hassan Zaraket, Roberta Giordo, Arduino A. Mangoni, Suzanne A. Nasser, Hadi M. Yassine, Manal Fardoun and Nadia Soudani. Their work appears in journals such as Frontiers in Immunology, Nutrition Reviews, Food Bioscience, Biomedicine & Pharmacotherapy and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.